Ampiroxicam Explained
Ampiroxicam (INN) is a non-steroidal anti-inflammatory drug (NSAID). It is a prodrug of piroxicam.[1] It has been studied for potential anticancer activity, but preliminary results did not show evidence of such activity.[2] [3]
Notes and References
- Carty TJ, Marfat A, Moore PF, Falkner FC, Twomey TM, Weissman A . Ampiroxicam, an anti-inflammatory agent which is a prodrug of piroxicam . Agents and Actions . 39 . 3–4 . 157–165 . July 1993 . 8304243 . 10.1007/BF01998969 . 24284281 .
- Choi KH, Shim JH, Huong LD, Cho NP, Cho SD . Inhibition of myeloid cell leukemia-1 by tolfenamic acid induces apoptosis in mucoepidermoid carcinoma . Oral Diseases . 17 . 5 . 469–475 . July 2011 . 21496182 . 10.1111/j.1601-0825.2010.01774.x .
- Shim JH, Shin JA, Jung JY, Choi KH, Choi ES, Cho NP, Kong G, Ryu MH, Chae JI, Cho SD . Chemopreventive effect of tolfenamic acid on KB human cervical cancer cells and tumor xenograft by downregulating specificity protein 1 . European Journal of Cancer Prevention . 20 . 2 . 102–111 . March 2011 . 21131823 . 10.1097/CEJ.0b013e328341e38f .